Tudor Investment Corp’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Tudor Investment Corp’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-31,909	Closed	-$33K	–	1483
2019 Q1	$33K	Hold	31,909	–	–	﹤0.01%	1061
2018 Q4	$24K	Hold	31,909	–	–	﹤0.01%	974
2018 Q3	$68K	Hold	31,909	–	–	﹤0.01%	1040
2018 Q2	$74K	Hold	31,909	–	–	﹤0.01%	991
2018 Q1	$101K	Sell	31,909 -8,886	-22%	-$24.5K	﹤0.01%	921
2017 Q4	$167K	Buy	40,795 +8,746	+27%	+$38.1K	﹤0.01%	986
2017 Q3	$145K	Buy	32,049 +9,149	+40%	+$37.1K	﹤0.01%	991
2017 Q2	$76K	Buy	+22,900	New	+$95K	﹤0.01%	972
2016 Q2	–	Sell	-14,800	Closed	-$150K	–	2141
2016 Q1	$150K	Buy	+14,800	New	+$174K	﹤0.01%	1558

Tudor Investment Corp's OMED Position: Q2 2019 in Review

Tudor Investment Corp sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 31,909 shares — an estimated $33K sold.

Tudor Investment Corp first reported a position in OMED in Q1 2016 and held it in 9 quarters. The position peaked at $167K in Q4 2017. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Tudor Investment Corp reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Tudor Investment Corp sold 31,909 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $33K.
Tudor Investment Corp first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2016 and held it in 9 quarters.
Tudor Investment Corp's OncoMed Pharmaceuticals, Inc. position peaked at $167K in Q4 2017.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Tudor Investment Corp's 13F filing for Q2 2019, filed 14 Aug 2019.